Innorna's broad-spectrum SARS-CoV-2 mRNA vaccine receives Phase II clinical trial approval from FDA
FDA has approved Phase II trial for IN002.5.1 SARS-CoV-2 mRNA vaccine. This approval paves the way for the development of combined respiratory virus vaccines. UNITED STATES, April 24, 2024 /EINPresswire.com/ -- Innorna, a clinical-stage biotech …